AI-driven healthcare

Our AI-based technologies are accurate to predict the onset and development of diseases and improve their diagnosis, prognosis and therapy


Involving users

According to the required level of interaction, we include users in the data-analysis process, and provide participatory, user-driven decision support systems.

Organizing and selecting medical data

Profile, normalize, filter, avoid redundancy, structure, standardize and integrate multi-source data to provide correct, unique and consistent data for clinical and research analyses.

Applying advanced data analytics

For segmentation, hidden-pattern extraction, classification, and for generation of predictive models.

Providing informative data features

We allow users monitoring our technology outcomes with respect to the expected results, and interpreting its added value in supporting their decisions.


The impact of our products and services on patients, physicians and researchers

Our applications of personalized medicine provide the risk of single patient to develop, being affected by or progress to a disease. 

65 +

Sites using DeepTrace technologies for clinical practice and research, including hospitals, private clinics and research centers of excellence

785000 +

Images analysed by our solutions with automatic reports providing quantitative and predictive information generated at a single-patient level

45 +

Peer-reviewed scientific papers published in top-tier journals

Products

Our products are applications of our intelligent technologies to real clinical needs

Predict the risk of Alzheimer's disease dementia
Predict the risk of breast cancer
Predict the risk of ovarian cancer
Image Analytics/Radiomics and AI-based tools for Research and Statistical Analyses
As featured in

We are researchers with acknowledged scientific achievements in the field of artificial intelligence and imaging in the visible and invisible spectrum, passionate in transforming new enabling technologies in disruptive sustainable solutions changing social paradigms.


We come from and collaborate with excellent research institutions, such as the National Research Council, the University of Milan-Bicocca and the SDA Bocconi school (Italy), the University of Bath (UK), and the École Polytechnique Fédérale de Lausanne (Switzerland).